Mandate

Vinge advises SCA in connection with the financing for the acquisition of BSN Medical from EQT

December 21, 2016

Vinge has advised SCA in the negotiations with the banks regarding financing in connection with SCA’s acquisition of the German company BSN Medical, a leading medico technical company, from EQT.

BSN Medical develops, manufactures, markets and sells products within treatment of wounds, compression treatment and orthopaedics. The enterprise value amounts to EUR 2 740 000 000 (based on an estimated net debt as per 31 December 2016). The acquisition will be completely loan-financed and SCA has a binding credit assurance available. Clifford Chance in Germany represented SCA in relation to the acquisition and the banks were represented by Clifford Chance in London.

The transaction is conditional upon the salient regulatory approvals and is expected to be completed during the second quarter of 2017. The financial conditions governing the transaction have not been made public.
 
Vinge’s team consisted of Mikael Ståhl, Helena Håkansson and Lionardo Ojeda.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025